BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31622786)

  • 1. Down-regulation of RalGTPase-Activating Protein Promotes Colitis-Associated Cancer via NLRP3 Inflammasome Activation.
    Iida T; Hirayama D; Minami N; Matsuura M; Wagatsuma K; Kawakami K; Nagaishi K; Nojima M; Ikeuchi H; Hirota S; Shirakawa R; Horiuchi H; Nakase H
    Cell Mol Gastroenterol Hepatol; 2020; 9(2):277-293. PubMed ID: 31622786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of Ral GTPase-activating protein promotes tumor invasion and metastasis of bladder cancer.
    Saito R; Shirakawa R; Nishiyama H; Kobayashi T; Kawato M; Kanno T; Nishizawa K; Matsui Y; Ohbayashi T; Horiguchi M; Nakamura T; Ikeda T; Yamane K; Nakayama E; Nakamura E; Toda Y; Kimura T; Kita T; Ogawa O; Horiuchi H
    Oncogene; 2013 Feb; 32(7):894-902. PubMed ID: 22450745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ral GTPase Activation by Downregulation of RalGAP Enhances Oral Squamous Cell Carcinoma Progression.
    Gao P; Liu S; Yoshida R; Shi CY; Yoshimachi S; Sakata N; Goto K; Kimura T; Shirakawa R; Nakayama H; Sakata J; Kawashiri S; Kato K; Wang XY; Horiuchi H
    J Dent Res; 2019 Aug; 98(9):1011-1019. PubMed ID: 31329042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arctigenin disrupts NLRP3 inflammasome assembly in colonic macrophages via downregulating fatty acid oxidation to prevent colitis-associated cancer.
    Qiao S; Lv C; Tao Y; Miao Y; Zhu Y; Zhang W; Sun D; Yun X; Xia Y; Wei Z; Dai Y
    Cancer Lett; 2020 Oct; 491():162-179. PubMed ID: 32861708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overproduction of Gastrointestinal 5-HT Promotes Colitis-Associated Colorectal Cancer Progression via Enhancing NLRP3 Inflammasome Activation.
    Li T; Fu B; Zhang X; Zhou Y; Yang M; Cao M; Chen Y; Tan Y; Hu R
    Cancer Immunol Res; 2021 Sep; 9(9):1008-1023. PubMed ID: 34285037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy in colitis-associated colon cancer: exploring its potential role in reducing initiation and preventing IBD-Related CAC development.
    Jin X; You L; Qiao J; Han W; Pan H
    Autophagy; 2024 Feb; 20(2):242-258. PubMed ID: 37723664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Nucleotide Analog Prevents Colitis-Associated Cancer via Beta-Catenin Independently of Inflammation and Autophagy.
    Sheng YH; Giri R; Davies J; Schreiber V; Alabbas S; Movva R; He Y; Wu A; Hooper J; McWhinney B; Oancea I; Kijanka G; Hasnain S; Lucke AJ; Fairlie DP; McGuckin MA; Florin TH; Begun J
    Cell Mol Gastroenterol Hepatol; 2021; 11(1):33-53. PubMed ID: 32497793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the mechanism of local and extra-intestinal tissue manifestations in AOM-DSS-induced carcinogenesis in BALB/c mice: role of PARP-1, NLRP3, and autophagy.
    Singla S; Jena G
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4321-4337. PubMed ID: 38091080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer.
    Allen IC; TeKippe EM; Woodford RM; Uronis JM; Holl EK; Rogers AB; Herfarth HH; Jobin C; Ting JP
    J Exp Med; 2010 May; 207(5):1045-56. PubMed ID: 20385749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
    He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
    Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel PAK1-Notch1 Axis Regulates Crypt Homeostasis in Intestinal Inflammation.
    Frick A; Khare V; Jimenez K; Dammann K; Lang M; Krnjic A; Gmainer C; Baumgartner M; Mesteri I; Gasche C
    Cell Mol Gastroenterol Hepatol; 2021; 11(3):892-907.e1. PubMed ID: 33189893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GPR65 (TDAG8) inhibits intestinal inflammation and colitis-associated colorectal cancer development in experimental mouse models.
    Marie MA; Sanderlin EJ; Satturwar S; Hong H; Lertpiriyapong K; Donthi D; Yang LV
    Biochim Biophys Acta Mol Basis Dis; 2022 Jan; 1868(1):166288. PubMed ID: 34628032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth differentiation factor 11 ameliorates experimental colitis by inhibiting NLRP3 inflammasome activation.
    Wang L; Wang Y; Wang Z; Qi Y; Zong B; Liu M; Li X; Zhang X; Liu C; Cao R; Ma Y
    Am J Physiol Gastrointest Liver Physiol; 2018 Dec; 315(6):G909-G920. PubMed ID: 30188752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary cholesterol promotes AOM-induced colorectal cancer through activating the NLRP3 inflammasome.
    Du Q; Wang Q; Fan H; Wang J; Liu X; Wang H; Wang Y; Hu R
    Biochem Pharmacol; 2016 Apr; 105():42-54. PubMed ID: 26921636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of RalGTPase-activating protein promotes invasion of prostatic epithelial cells and progression from intraepithelial neoplasia to cancer during prostate carcinogenesis.
    Uegaki M; Kita Y; Shirakawa R; Teramoto Y; Kamiyama Y; Saito R; Yoshikawa T; Sakamoto H; Goto T; Akamatsu S; Yamasaki T; Inoue T; Suzuki A; Horiuchi H; Ogawa O; Kobayashi T
    Carcinogenesis; 2019 Dec; 40(12):1535-1544. PubMed ID: 31058283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-(2-Oxo-2-phenylethylidene)-2,3,6,7-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4(11bH)-one (compound 1), a novel potent Nrf2/ARE inducer, protects against DSS-induced colitis via inhibiting NLRP3 inflammasome.
    Wang Y; Wang H; Qian C; Tang J; Zhou W; Liu X; You Q; Hu R
    Biochem Pharmacol; 2016 Feb; 101():71-86. PubMed ID: 26588861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galectin-3 Plays an Important Pro-inflammatory Role in the Induction Phase of Acute Colitis by Promoting Activation of NLRP3 Inflammasome and Production of IL-1β in Macrophages.
    Simovic Markovic B; Nikolic A; Gazdic M; Bojic S; Vucicevic L; Kosic M; Mitrovic S; Milosavljevic M; Besra G; Trajkovic V; Arsenijevic N; Lukic ML; Volarevic V
    J Crohns Colitis; 2016 May; 10(5):593-606. PubMed ID: 26786981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear Receptor Subfamily 1 Group D Member 1 Regulates Circadian Activity of NLRP3 Inflammasome to Reduce the Severity of Fulminant Hepatitis in Mice.
    Pourcet B; Zecchin M; Ferri L; Beauchamp J; Sitaula S; Billon C; Delhaye S; Vanhoutte J; Mayeuf-Louchart A; Thorel Q; Haas JT; Eeckhoute J; Dombrowicz D; Duhem C; Boulinguiez A; Lancel S; Sebti Y; Burris TP; Staels B; Duez HM
    Gastroenterology; 2018 Apr; 154(5):1449-1464.e20. PubMed ID: 29277561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The NLRP3 inflammasome contributes to host protection during Sporothrix schenckii infection.
    Gonçalves AC; Ferreira LS; Manente FA; de Faria CMQG; Polesi MC; de Andrade CR; Zamboni DS; Carlos IZ
    Immunology; 2017 Jun; 151(2):154-166. PubMed ID: 28140444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Libertellenone M, a diterpene derived from an endophytic fungus Phomopsis sp. S12, protects against DSS-induced colitis via inhibiting both nuclear translocation of NF-κB and NLRP3 inflammasome activation.
    Fan M; Xiang G; Chen J; Gao J; Xue W; Wang Y; Li W; Zhou L; Jiao R; Shen Y; Xu Q
    Int Immunopharmacol; 2020 Mar; 80():106144. PubMed ID: 31927507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.